Overview

Capecitabine in the Perioperative Treatment of Rectal Cancer

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study compares capecitabine with standard 5-FU in the perioperative treatment of locally advanced rectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Universitätsmedizin Mannheim
Treatments:
Capecitabine
Fluorouracil